Startups
Current imaging techniques for bladder cancer only visualize the bladder wall surface. Scinvivos technology enables the urologist to improve his diagnosis.
Investors 2
| Date | Name | Website |
| Sign up to see | Sign up to see | Sign up to see |
| Vectrix | vectrix.nl |
Mentions in press and media 5
| Date | Title | Description |
| Sign up to see | Sign up to see | Sign up to see |
| Nov 13, 2025 | America's first Ismaili Center set to open in Houston in December | The long-awaited Ismaili Center, Houston is set to open to the public next month. The 11-acre site has been painstakingly designed and constructed to offer indoor and outdoor public spaces for Houstonians to enjoy, connect, and engage. As t... |
| Feb 21, 2024 | Eindhoven-based Scinvivo secures €4.7 million to radically improve bladder cancer diagnostics | |
| Mar 14, 2022 | Scinvivo secures 1 Million investment for in human clinical trials & CE | Press Release Eindhoven, March 10th, 2022 Scinvivo 1 million investment secured towards in human clinical trials & CE for game-changing cancer diagnostics Scinvivo, a MedTech startup based in Eindhoven, has closed an investment rou... |
| Scinvivo | “Scinvivo aims to revolutionize cancer diagnostics by providing the medical professionals with the next gen in vivo imaging platform.” |
Reviews 0
FAQ about Scinvivo
Who has invested in Scinvivo?
Parsers VC lists 2 investors of Scinvivo, among them Vectrix.
What has the press written about Scinvivo?
Parsers VC has collected 5 articles mentioning Scinvivo, among them “America's first Ismaili Center set to open in Houston in December” (Nov 13, 2025) and “Eindhoven-based Scinvivo secures €4.7 million to radically improve bladder cancer diagnostics” (Feb 21, 2024).
Is Scinvivo still active?
Yes, Scinvivo is active; its latest activity on Parsers VC dates from Nov 14, 2025.